Ignite Creation Date:
2025-12-25 @ 12:06 AM
Ignite Modification Date:
2026-02-24 @ 11:10 AM
Study NCT ID:
NCT02728258
Status:
COMPLETED
Last Update Posted:
2022-02-15
First Post:
2016-03-30
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer
Sponsor:
NRG Oncology
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Endometrial Endometrioid Adenocarcinoma | View |
| None | Endometrial Mixed Cell Adenocarcinoma | View |
| None | Endometrial Serous Adenocarcinoma | View |
| None | Endometrial Undifferentiated Carcinoma | View |
| None | Metastatic Endometrioid Adenocarcinoma | View |
| None | Recurrent Uterine Corpus Cancer | View |
Keywords: